AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 75 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $20,471,000 | +175.6% | 594,207 | +33.7% | 0.01% | +400.0% |
| Q2 2020 | $7,428,000 | +28.3% | 444,530 | +10.7% | 0.00% | 0.0% |
| Q1 2020 | $5,790,000 | -43.7% | 401,472 | +30.6% | 0.00% | -50.0% |
| Q4 2019 | $10,290,000 | +15.8% | 307,452 | -27.6% | 0.00% | -33.3% |
| Q3 2019 | $8,887,000 | -14.7% | 424,389 | -15.2% | 0.00% | +200.0% |
| Q2 2019 | $10,422,000 | +157.8% | 500,608 | +176.8% | 0.00% | -50.0% |
| Q1 2019 | $4,042,000 | +42.1% | 180,834 | +52.1% | 0.00% | +100.0% |
| Q4 2018 | $2,844,000 | -44.8% | 118,895 | -37.1% | 0.00% | -50.0% |
| Q3 2018 | $5,155,000 | +13.7% | 189,000 | +12.1% | 0.00% | 0.0% |
| Q2 2018 | $4,535,000 | -77.9% | 168,670 | -73.8% | 0.00% | -71.4% |
| Q1 2018 | $20,514,000 | +289.9% | 644,471 | +363.3% | 0.01% | +250.0% |
| Q4 2017 | $5,261,000 | +10.7% | 139,111 | -27.4% | 0.00% | 0.0% |
| Q3 2017 | $4,751,000 | +2021.0% | 191,664 | +1658.4% | 0.00% | – |
| Q2 2017 | $224,000 | -5.5% | 10,900 | 0.0% | 0.00% | – |
| Q1 2017 | $237,000 | -86.8% | 10,900 | -87.5% | 0.00% | – |
| Q4 2016 | $1,790,000 | +764.7% | 87,494 | +356.6% | 0.00% | – |
| Q2 2016 | $207,000 | -78.7% | 19,164 | -50.1% | 0.00% | – |
| Q3 2015 | $972,000 | – | 38,373 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|